1[1]Ross R.Atherosclerosis: an inflammatory disease[J].New Engl J Med,1999,340(2): 115
2[2]Mickelson JK,Lakkis NM,villaral-Levy G,et al.Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease [J].J Am Coll Cardiol,1996,28(2): 345
3[3]Michelson AD,Barnard MR,Kruegar LA,et al.Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons,human coronary intervention,and human acute myocardial infarction[J].Circulation,2001,104(13): 1533
7[7]Stefano Fiorucci,Rosaria Meli,Mariarosaria Bucciand,et al.Dual inhibitors of cyclooxygenase and 5-lipoxygenase.A new avenue in anti-inflammatory therapy [J].Biochem Pharmacol,2001,62(11): 1433
8[8]Celotti F,Laufer S.Anti-inflammatory drugs: new multitarget compounds to face an old problem.The dual inhibition concept[J].Pharmacol Res,2001,43(5): 429
10[10]Tries S,Neupert W,Laufer S,et al.The mechanism of action of the new anti-inflammatory compound ML3000: inhibition of 5-LOX and COX-1/2[J].Inflamm Res,2002,51(3): 135
10Furuya T, Hirotani M, Matsuzawa M. N6 - (2-hydroxyethyl) aden- osine, a biologically active compound from cultured mycelia of Cordyceps and lsaria species [ J ] . Phytochemistry, 1983, 22 (11) :2509.
